Zealand Pharma starts registrational Phase 3 ZUPREME for petrelintide
Zealand Pharma said it has initiated the registrational Phase 3 ZUPREME program of petrelintide in people with overweight or obesity.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.